one
challeng
characterist
novel
pandem
variou
degre
sever
symptom
asymptomat
lifethreaten
form
recent
report
zhang
et
al
consid
biochem
paramet
elev
level
infectionrel
biomark
inflammatori
cytokin
neutrophilia
lymphocytopenia
well
low
tcell
count
seem
correl
sever
case
infect
attempt
identifi
prognost
paramet
clinic
factor
significantli
correl
higher
risk
acut
respiratori
distress
syndrom
ard
death
older
age
group
high
fever
comorbid
focus
attent
last
group
factor
recent
studi
confirm
strong
correl
sever
infect
caus
presenc
hypertens
experi
almost
patient
sever
ard
hypertens
unpublish
data
sever
studi
demonstr
strong
correl
hypertens
nitric
oxid
high
level
blood
pressur
patholog
condit
character
endotheli
dysfunct
avail
impair
concomit
increas
releas
dysfunct
endothelium
extrapol
previou
point
viru
could
determin
sever
cytokin
storm
high
level
low
cell
patient
basal
level
cytokin
ie
higher
level
lower
hypothesi
could
explain
hypertens
patient
seem
suscept
healthi
patient
infect
moreov
consid
preliminari
report
posit
effect
offlabel
treatment
tocilizumab
human
monoclon
antibodi
receptor
adopt
therapi
rheumatoid
arthriti
improv
outcom
sever
could
indic
role
drug
reduc
sever
inflamm
lower
nevertheless
efficaci
tocilizumab
seem
partial
start
consider
focus
attent
role
postul
possibl
role
phosphodiesteras
type
inhibitor
sildenafil
citrat
tadalafil
increas
level
inde
repres
standard
medic
treatment
erectil
dysfunct
nevertheless
drug
current
use
diseas
manag
pulmonari
fibrosi
arteri
pulmonari
hypertens
sever
anim
test
confirm
mitig
lung
injuri
decreas
concentr
proinflammatori
cytokin
reduc
migrat
polymorphonuclear
lung
role
antivir
therapi
alreadi
test
demonstr
inhibit
role
coronaviru
replic
moreov
recent
guidelin
manag
mention
kind
drug
consid
biochem
mechan
involv
infect
previou
experi
justifi
offlabel
use
sildenafil
citrat
similar
antivir
drug
possibl
synerg
role
earli
complimentari
drug
treatment
infect
consid
therapi
efficaci
demonstr
use
prophylaxi
modifi
evolut
novel
pandem
diseas
none
